A rigorous framework to interpret water relaxivity. The case study of a Gd(III) complex with an alpha-cyclodextrin derivative.

We present a general theoretical framework suitable for an economical, but rigorous, analysis of the relaxivity and EPR data of paramagnetic metal complexes. This framework is based on the so-called Grenoble method that properly accounts for the fluctuations of the "static" zero-field splitting Hamiltonian and avoids the misinterpretation of experimental data, which occurs with the Solomon, Bloembergen, and Morgan (SBM) formalism and may lead to erroneous conclusions. The applicability of the SBM approximation is discussed. Our approach is implemented in the case of a new Gd(3+) chelate with a cyclodextrin derivative ligand hexakis(2-O-carboxymethyl-3,6-anhydro)-alpha-cyclodextrin (ACX), designed to obtain lanthanide complexes of enhanced stability in comparison to natural cyclodextrins. The introduction of carboxymethyl units on the six residual hydroxyl groups of an alpha-per-3,6-anhydro cyclodextrin leads to mono- and binuclear Ln(3+) complexes with log beta(110) approximately = 7.5. The GdACX complex induces large water proton relaxivity in 0.1 M KCl aqueous solution. The molecular parameters governing the longitudinal (r1) and transverse (r2) relaxivities above 1 T are obtained through simple SBM-like theoretical expressions and complementary experimental techniques. The metal hydration state, the translational diffusion coefficient of the complex, and its rotational correlation time are derived from luminescence lifetime studies, pulse-field gradient NMR, and deuteron quadrupolar relaxation, respectively. The high relaxivity induced by the GdACX complex is attributed to its high hydration state in the presence of potassium ions and to a rotational correlation time lengthened by the hydrophilic character of the ACX scaffold.

Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.

In magnetic resonance imaging (MRI), cerebral blood volume (CBV) quantification is dependent on the MRI sequence and on the properties of the contrast agents (CAs). By using the rapid steady-state T(1) method, we show the potential of gadolinium per (3,6-anhydro) alpha-cyclodextrin (Gd-ACX), a new MRI paramagnetic CA (inclusion complex of Gd(3+) with per (3,6-anhydro)-alpha-cyclodextrin), for the CBV quantification in the presence of blood-brain barrier lesions. After biocompatibility and relaxivity experiments, in vivo experiments on rats were performed on a C6 tumor model with 0.05 mmol Gd-ACX/kg (<1/10 of the median lethal dose) injected at a 25 mmol/L concentration, inducing neither nephrotoxicity nor hemolysis. On T(1)-weighted images, a signal enhancement of 170% appeared in vessels after injection, but not in the tumor (during the 1 h of observation), in contrast to the 90% signal enhancement obtained with Gd-DOTA (a clinical MRI CA) injected at a T(1) isoefficient dose. This result shows the absence of Gd-ACX extravasation into the tumor tissue and its confinement to the vascular space. Fractional CBV values were found similar to Gd-ACX and Gd-DOTA in healthy brain tissue and in the contralateral hemisphere of tumor-bearing rats, whereas only Gd-ACX was appropriate for CBV quantification in tumor regions.

Inclusion complexes of trivalent lutetium cations with an acidic derivative of per(3,6-anhydro)-alpha-cyclodextrin.

The cyclodextrin derivative (hexakis (2-O-carboxymethyl-3,6-anhydro)-alpha-cyclodextrin) forms mono- and bimetallic complexes with lutetium(III) in aqueous solution; the X-ray structure of the binuclear complex [Lu2(ACX)(H2O)2] is the first example of a lanthanide-cyclodextrin inclusion complex.